PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia, USA.\', \'Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.\', \'Emory Healthcare, Atlanta, Georgia, USA.\', \'Department of Anesthesiology, Emory University, Atlanta, Georgia, USA.\', \'Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'NIOSH, Centers for Disease Control and Prevention, Morgantown, West Virgina, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa1880
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33506256
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March-May 2020.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all